Mobia Medical has appointed Myriam Curet, M.D., to its board as an independent director effective July 30, 2026. Dr. Curet is a Clinical Professor of Surgery at Stanford University School of Medicine and brings decades of clinical and executive leadership experience, including her prior role at Intuitive Surgical. She currently serves on the boards of Inspire Medical Systems and Stereotaxis, and previously served as a director of Nektar Therapeutics. Mobia Medical is a commercial-stage medical device company focused on stroke recovery, with its Vivistim Paired VNS System being the first FDA-approved implantable solution for improving upper limb function in chronic ischemic stroke survivors.
Mobia Medical, Inc. Common StockAppointment of experienced independent director strengthens board.
Inspire Medical Systems Inc
Intuitive Surgical Inc
Stereotaxis Inc
Nektar Therapeutics